A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/17/2004	EP1476455A1 PARTIAL AND FULL AGONISTS OF A sb 1 /sb ADENOSINE RECEPTORS
11/17/2004	EP1476454A1 Binding epitopes for helicobacter pylori and use thereof
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476187A2 Methods of extending corneal graft survival
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476177A2 Peptide constructs for treating disease
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476120A2 Treatment methods using anti-cd22 antibodies
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	EP1392713A4 Liver x receptor agonists
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0819763B1 Engineered acarid allergen and process for producing the same
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547584A Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547486A Antibodies to OPGL
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1546491A Pteridine derivatives with nitric oxide synthase inhibitor function
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546165A Technique for preparing transfer factor - complete filtering method
11/17/2004	CN1546068A Modified technique for making zedoary turmeric oil and glucose injection
11/17/2004	CN1546027A Dripping pills for treating allergic disease and its preparation process
11/17/2004	CN1175899C Medicine composition and preparation and use thereof
11/17/2004	CN1175807C Disulfide derivatives useful for treating allergic diseases
11/16/2004	US6818780 Application in medicine for treatment of disorders of immunological system
11/16/2004	US6818761 Comprises heteropolypolysaccharide composed of alternating straight and branched portions consisting of partially acetylated and methylated galacturonic acid residues linked to rhamnose, arabinose and galactose
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818640 2-imino-1,3-thiazine derivatives
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818613 A parenteral sustained-release formulation of e.g., erythropoietin, that is easily manufactured, safe, stable and efficient comprising the protein, a buffer, tonicity agent and sodium carboxymethylcellulose
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818232 Oat extracts: refining, compositions and methods of use
11/16/2004	US6818230 Antiproliferative effect can be achieved by subjecting conditioned medium obtained by culturing the structures of the invention in culture medium to filtration; anticancer agents
11/16/2004	US6818221 Adjuvants and processes to induce a specific type of immune response
11/16/2004	CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/11/2004	WO2004097019A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	WO2004096851A1 Galectin 9-inducing factor
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	WO2004096752A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
11/11/2004	WO2004096275A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096273A1 Methods for treating interleukin-6 related diseases
11/11/2004	WO2004096270A1 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
11/11/2004	WO2004096249A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof
11/11/2004	WO2004096247A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004083231A3 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
11/11/2004	WO2004072091B1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
11/11/2004	WO2004069274A3 Sensitizing cells for apoptosis by selectively blocking cytokines
11/11/2004	WO2004048410A3 T-cell receptors
11/11/2004	WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004	US20040225140 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224938 Substituted benzo [b] azepin-2-one compounds
11/11/2004	US20040224932 crystal structure; antiinflammatory agents; antiallergens
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224323 PAK5 screening methods
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	CA2523582A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases

1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1172